Orchestra BioMed (OBIO) Institutional Ownership $2.55 -0.08 (-3.04%) Closing price 04:00 PM EasternExtended Trading$2.64 +0.09 (+3.53%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)CurrentInstitutional OwnershipPercentage53.20%Number ofInstitutional Buyers(last 12 months)28TotalInstitutional Inflows(last 12 months)$16.92MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$1.41M Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OBIO Institutional Buying and Selling by Quarter Orchestra BioMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 27,922$75K0.0%+1,137.7%0.072% 8/15/2025 Bridgeway Capital Management LLC25,000$67K0.0%N/A0.065% 8/15/2025 Bank of America Corp DE21,577$58K0.0%+35.7%0.056% 8/14/2025 Jane Street Group LLC18,513$50K0.0%N/A0.048% 8/14/2025 The Manufacturers Life Insurance Company 32,518$87K0.0%-22.5%0.084% 8/14/2025 NewEdge Advisors LLC44,083$118K0.0%N/A0.114% 8/13/2025 Marshall Wace LLP49,465$133K0.0%N/A0.128% 8/12/2025 XTX Topco Ltd16,817$45K0.0%N/A0.044% 8/12/2025 Catalyst Funds Management Pty Ltd11,400$31K0.0%N/A0.030% 8/11/2025 Knott David M Jr100,000$268K0.1%N/A0.259% Get the Latest News and Ratings for OBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter. 8/8/2025 Creative Planning15,000$40K0.0%N/A0.039% 8/8/2025 Geode Capital Management LLC302,082$810K0.0%-49.3%0.782% 8/1/2025 Y Intercept Hong Kong Ltd45,447$122K0.0%N/A0.119% 7/24/2025 IFP Advisors Inc85,358$229K0.0%-47.3%0.223% 6/27/2025 Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127% 5/16/2025 Goldman Sachs Group Inc.48,729$209K0.0%-21.6%0.127% 5/13/2025 HighTower Advisors LLC61,000$261K0.0%-10.9%0.159% 5/12/2025 Nuveen LLC41,729$179K0.0%N/A0.109% 5/9/2025 Deutsche Bank AG20,219$87K0.0%+67.3%0.053% 5/5/2025 IFP Advisors Inc161,921$693K0.0%+106.4%0.423% 2/17/2025 Millennium Management LLC21,513$86K0.0%N/A0.057% 2/17/2025 Citadel Advisors LLC12,279$49K0.0%-39.0%0.032% 2/17/2025 Bank of America Corp DE23,780$95K0.0%+42.0%0.063% 2/14/2025 Boxer Capital Management LLC238,193$953K0.1%N/A0.627% 2/14/2025 Northern Trust Corp236,761$947K0.0%+2.5%0.623% 2/14/2025 The Manufacturers Life Insurance Company37,009$148K0.0%+11.1%0.097% 2/14/2025 Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282% 2/13/2025 Barclays PLC37,786$152K0.0%+18.9%0.099% 2/13/2025 Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035% 2/12/2025 Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506% 2/12/2025 JPMorgan Chase & Co.49,405$198K0.0%+354.5%0.130% 2/7/2025 HighTower Advisors LLC68,500$274K0.0%+34.3%0.180% 1/17/2025 SG Americas Securities LLC12,785$51K0.0%+26.0%0.034% 11/21/2024 SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032% 11/19/2024 Barclays PLC31,785$163K0.0%+281.3%0.084% 11/16/2024 Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492% 11/15/2024 Barclays PLC31,785$163K0.0%+281.3%0.084% 11/15/2024 Jane Street Group LLC19,070$98K0.0%-19.8%0.050% 11/15/2024 State Street Corp429,613$2.21M0.0%+12.4%1.130% 11/15/2024 RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587% Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now.11/13/2024 The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088% 11/12/2024 Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574% 11/1/2024 ABLE Financial Group LLC13,402$69K0.0%N/A0.035% 10/3/2024 SG Americas Securities LLC10,143$52K0.0%N/A0.028% 8/16/2024 SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056% 8/15/2024 The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118% 8/1/2024 Rhumbline Advisers26,439$215K0.0%+192.7%0.074% 7/26/2024 Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197% 5/15/2024 Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596% 5/11/2024 Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062% 2/1/2024 New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010% 10/27/2023 Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014% 10/27/2023 TD Asset Management Inc92,678$808K0.0%+100.0%0.259% 10/24/2023 Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113% 10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009% 10/13/2023 Arkadios Wealth Advisors51,595$450K0.0%N/A0.144% 8/24/2023 Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744% 8/11/2023 Atika Capital Management LLC64,651$453K0.0%N/A0.181% 5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230% 5/15/2023 RTW Investments LP5,118,507$100.17M2.1%N/A45.652% 4/18/2023 IFP Advisors Inc2,980$34K0.0%N/A0.027% (Data available from 1/1/2016 forward) OBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OBIO shares? During the previous two years, 41 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), State Street Corp ($2.21M), Price T Rowe Associates Inc. MD ($1.95M), Charles Schwab Investment Management Inc. ($1.12M), Boxer Capital Management LLC ($953K), and Northern Trust Corp ($947K).Learn more on Orchestra BioMed's institutional investors. What percentage of Orchestra BioMed's stock is owned by institutional investors? 53.20% of Orchestra BioMed's stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings. Which institutional investors have been buying Orchestra BioMed's stock? Of the 36 institutional investors that purchased Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($2.59M), Boxer Capital Management LLC ($238.19K), Knott David M Jr ($100K), IFP Advisors Inc ($83.48K), Bank of New York Mellon Corp ($65.25K), Barclays PLC ($52.90K), and Arkadios Wealth Advisors ($51.60K). How much institutional buying is happening at Orchestra BioMed? Institutional investors have bought a total of 3,562,853 shares in the last 24 months. This purchase volume represents approximately $16.92M in transactions. Which of Orchestra BioMed's major shareholders have been selling company stock? Of the 9 institutional investors that sold Orchestra BioMed's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Geode Capital Management LLC ($293.35K), IFP Advisors Inc ($76.56K), Goldman Sachs Group Inc. ($26.82K), Price T Rowe Associates Inc. MD ($25.49K), The Manufacturers Life Insurance Company ($18.24K), Citadel Advisors LLC ($7.84K), and SkyView Investment Advisors LLC ($7.72K). How much institutional selling is happening at Orchestra BioMed? Institutional investors have sold a total of 468,229 shares in the last 24 months. This volume of shares sold represents approximately $1.41M in transactions. Related Companies TMCI Institutional Ownership DCTH Institutional Ownership BFLY Institutional Ownership SNWV Institutional Ownership RXST Institutional Ownership CLPT Institutional Ownership DRTS Institutional Ownership NPCE Institutional Ownership SKIN Institutional Ownership TCMD Institutional Ownership This page (NASDAQ:OBIO) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.